ALPN-101, a First-in-Class Dual ICOS/CD28 Antagonist, Suppresses Key Effector Mechanisms Underlying Rheumatoid and Psoriatic ArthritisLawrence Evans,Stacey Dillon,Katherine Lewis,Susan Bort,Erika Rickel,Jing Yang,Martin Wolfson,Sherri Mudri,Kayla Susmilch,Steven Levin,Sean MacNeil,Mark Rixon,Jan Hillson,Stanford Peng,Kristine SwiderekARTHRITIS & RHEUMATOLOGY（2019）引用 2|浏览20AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
